SR 172 Hawaii Senate · 2021 Regular Session

REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A MEDICINAL PSILOCYBIN AND PSILOCIN WORKING GROUP TO EXAMINE THE MEDICINAL AND THERAPEUTIC EFFECTS OF PSILOCYBIN AND PSILOCIN OR DEVELOP A LONG-TERM STRATEGIC PLAN TO ENSURE THE AVAILABILITY OF MEDICINAL PSILOCYBIN AND PSILOCIN OR PSILOCYBIN-BASED AND PSILOCIN-BASED PRODUCTS THAT ARE SAFE, ACCESSIBLE, AND AFFORDABLE FOR ELIGIBLE ADULT PATIENTS.

Bill status passed 3 of 5 stages cleared

Introduction

Mar 2021

Committee Review

Mar 2021

Senate Passage

Mar 2021

House Passage

Governor

Introduced Mar 12, 2021 Last action Jun 21, 2021

Floor votes

How they voted

This bill passed the Senate. No roll call record of that vote is available.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 31, 2021

Upper · Passed

Report and Resolution Adopted as amended (SD 1). Aye(s) with reservations: Senator(s) Fevella. Noes, 0 (none).

upper

Mar 30, 2021

Upper · Passed

Reported from HTH (Stand. Com. Rep. No. 1408) with recommendation of adoption, as amended (SD 1).

upper

Mar 29, 2021

Upper · Passed

The committee(s) on HTH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HTH were as follows: 5 Aye(s): Senator(s) Keohokalole, Baker, Moriwaki, San Buenaventura; Aye(s) with reservations: Senator(s) Fevella ; 0 No(es): none; and 0 Excused: none.

upper

Mar 25, 2021

Upper · Passed

The committee(s) on HTH has scheduled a public hearing on 03-29-21 1:20PM; Via Videoconference.

upper

Mar 16, 2021

Committee

Referred to HTH.

upper

Mar 12, 2021

Introduced

Offered.